Long-term follow-up of a phase I study o
✍
Marcos de Lima; Farhad Ravandi; Munir Shahjahan; Borje Andersson; Daniel Couriel
📂
Article
📅
2003
🏛
John Wiley and Sons
🌐
English
⚖ 77 KB
👁 2 views
## Abstract ## BACKGROUND Decitabine is a hypomethylating agent that has activity in patients with leukemia. The authors combined decitabine with busulfan and cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic stem cell transplantation. ## METHODS Patients with high‐ris